Califf Again Faults Low Prices For Shortages, Seeks Data Collection Power

FDA Commissioner Robert Califf still points to low generic drug prices as a key contributor to drug shortages, but he also is continuing his quest for new FDA power to gather information about the drug supply chain despite congressional Republicans’ skepticism that would help avert shortages. Speaking at a webinar hosted by the Alliance for a Stronger FDA Tuesday (Aug. 25), Califf said FDA has long been attuned to the problem of drug shortages, despite the agency’s limited capacity to...